Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022

DeSilva, MB; Mitchell, PK; Klein, NP; Dixon, BE; Tenforde, MW; Thompson, MG; Naleway, AL; Grannis, SJ; Ong, TC; Natarajan, K; Reese, SE; Zerbo, O; Kharbanda, AB; Patel, P; Stenehjem, E; Raiyani, C; Irving, SA; Fadel, WF; Rao, SCT; Han, JM; Reynolds, S; Davis, JM; Lewis, N; McEvoy, C; Dickerson, M; Dascomb, K; Valvi, NR; Barron, MA; Goddard, K; Vazquez-Benitez, G; Grisel, N; Mamawala, M; Embi, PJ; Fireman, B; Essien, IJ; Griggs, EP; Arndorfer, J; Gaglani, M

Mitchell, PK (通讯作者),Westat Corp, 1600 Res Blvd, Rockville, MD 20850 USA.

JOURNAL OF INFECTIOUS DISEASES, 2023; 227 (8): 961

Abstract

Background We assessed coronavirus disease 2019 (COVID-19) vaccination impact on illness severity among adults hospitalized with COVID-19, August 2021......

Full Text Link